miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein

por Huang, Ya-Qiang, Ling, Xiao-Hui, Yuan, Run-Qiang, Chen, Zhi-Yun, Yang, Sheng-Bang, Huang, Hong-Xing, Zhong, Wei-De, Qiu, Shao-Peng
Publicado 2017